Efficacy of Switching from Infliximab to Subcutaneous Golimumab in Patients with Rheumatoid Arthritis to Control Disease Activity or Adverse Events.
Saved in:
| Title: | Efficacy of Switching from Infliximab to Subcutaneous Golimumab in Patients with Rheumatoid Arthritis to Control Disease Activity or Adverse Events. |
|---|---|
| Authors: | Wakabayashi, Hiroki1 whiroki@clin.medic.mie-u.ac.jp, Inada, Hitoshi2, Nishioka, Yosuke3, Hasegawa, Masahiro1, Nishioka, Kusuki4, Sudo, Akihiro1 |
| Source: | Drugs in R&D. Mar2017, Vol. 17 Issue 1, p233-239. 7p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
